Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003391577 | SCV004110298 | likely pathogenic | DHTKD1-related disorder | 2023-08-08 | criteria provided, single submitter | clinical testing | The DHTKD1 c.2061G>A variant is predicted to result in premature protein termination (p.Trp687*). This variant has been reported in a patient with unknown phenotype (suppl. Table 4 in Niceta et al. 2015. PubMed ID: 25865493). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Nonsense variants in DHTKD1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. |
Labcorp Genetics |
RCV003778262 | SCV004666191 | pathogenic | 2-aminoadipic 2-oxoadipic aciduria | 2022-11-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp687*) in the DHTKD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DHTKD1 are known to be pathogenic (PMID: 23141293, 25860818). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with DHTKD1-related conditions. This variant is not present in population databases (gnomAD no frequency). |